
October 2026
Helus Pharma Inc is a clinical-stage pharmaceutical company developing proprietary novel serotonergic agonists (NSAs), which are synthetic molecules designed to activate serotonin pathways associated with neuroplasticity. These compounds are being investigated for potential use in the treatment of depression, anxiety, and other mental health conditions, areas where there is an unmet medical need. It aims to provide treatments designed for mental health disorders. The company is currently developing HLP003, a proprietary NSA, in Phase 3 clinical development for the adjunctive treatment of substantial depressive disorder. It operates in Canada, the United States, the United Kingdom, and Ireland. | $11 | +58% | $838M | $672M | - | (4.4x) | |||
Knight Therapeutics Inc is a specialty and generic drug manufacturing company. The company's principal business activity is focused on developing, acquiring, in-licensing, out-licensing, marketing, and distributing pharmaceutical products, consumer health products, and medical devices in Canada, Latin America and select international markets . The company finances other life sciences companies across the globe in order to generate interest income, strengthen relationships in the life sciences industry, and to secure product distribution rights. Geographically the company generates revenue from Brazil, Colombia, Argentina, Rest of LATAM, Canada, and Other, with the majority revenue generated from the Brazil region. | $7 | +77% | $727M | $666M | 2.1x | 17.5x | |||
Vitalhub Corp provides technology to Health and Human Service providers, including Hospitals, Regional Health Authorities, Mental Health, Long-Term Care, Home Health, and Community and Social Services. Vitalhub solutions span the categories of Electronic Health Records (EHR), Case Management, Care Coordination, Patient Flow, Operational Visibility, and Mobile Apps. It operates in one segment for its operations related to healthcare information systems in the mental health, long-term care, community health service, and hospital sectors. Geographically, it's available in Canada, the United Kingdom, Australia, the USA, Western Asia, and the Rest of the world, and the majority of the revenue comes from the United Kingdom. | $5 | -34% | $328M | $234M | 3.1x | 22.8x | |||
Everkind Wellness Inc is a Toronto-based emotional wellness company making mental and emotional support accessible, affordable, and stigma-free. It operates a digital platform that provides AI-powered journaling and personalized meditation services, designed to support daily emotional wellness and habit formation using evidence-based practices. | $0 | -- | $50M | $48M | - | - | |||
NetraMark Holdings Inc provides AI-powered insights and software solutions to optimize clinical trial design and outcomes for pharmaceutical sponsors. The company offers AI solutions to trial sponsors, CROs, and biotechnology companies across the globe. It earns revenue from its proprietary NetraAI platform, an advanced machine learning system purpose-built to analyze complex clinical trial data and identify meaningful patient subpopulations. | $0 | -46% | $44M | $42M | 137.1x | (11.4x) | |||
Rocket Doctor AI Inc delivers physician-built, AI-powered solutions designed to make high- quality healthcare accessible throughout the entire patient journey. A cornerstone of the company's proprietary technology is the Global Library of Medicine (GLM), a clinically validated decision support system developed with input from hundreds of physicians world-wide. Alongside the GLM and its AI-powered digital health platform and marketplace. The group empowers over 300 MDs to provide care to more than 700,000 patients. Itsproprietary technology software and systems enable doctors to independently launch and manage their own virtual or hybrid in-person practices - improving efficiency, restoring autonomy to MDs, and expanding patient access to care. | $0 | -37% | $41M | $41M | 33.4x | (4.1x) | |||
Diagnos Inc is engaged in the provision of software-based interpretation services to assist health specialists in the detection of diabetic retinopathy. The company provides image analysis services through CARA (Computer Assisted Retinal Analysis). It operates in a single business segment of Healthcare services. The company has a business presence in Canada, United States of America, Mexico, Chile and others. The company's key revenue is derived from Canada. | $0 | +36% | $40M | $40M | 860.8x | (13.8x) | |||
GuideAI Health Corp is a healthcare technology company using artificial intelligence to enable the early detection of vascular disease and support more precise treatment decisions. Its platform analyzes routine CT scans to identify peripheral vascular disease and other vascular conditions that are frequently missed or under-reported, generating structured, actionable reports for radiologists and treating clinicians. By surfacing disease earlier and matching findings to appropriate treatment pathways, it aims to improve patient outcomes while helping hospitals and radiology groups deliver more comprehensive vascular care. Its Platform Capabilities are AI-powered vascular imaging, Early detection of disease, subtle patterns and risk signals, Structured, consistent AI-generated, and Others. | $1 | -- | $38M | $35M | - | (1.8x) | |||
TempraMed Technologies Ltd through its subsidiary, engaged in developing patent-protected technology designed to serve a broad range of medical and consumer products. TempraMed's primary focus is revolutionizing storage and management of injectable for temperature-sensitive medications. This inventive technology ensures adequate temperature storage conditions to medications without requiring power source or human intervention for years. | $0 | -- | $29M | $30M | 16.5x | (1.7x) | |||
Conavi Medical Corp is focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. Its Novasight Hybrid System is the first system to combine both intravascular ultrasound (IVUS) and optical coherence tomography (OCT) to enable simultaneous and co-registered imaging of coronary arteries. | $0 | -- | $14M | $26M | 4.0x | (4.5x) | |||
1933 Industries Inc is a vertically integrated cannabis company. The company is focused on the cultivation and manufacturing of cannabis consumer-branded goods. The Company operates in three segments, referred to as AMA, Infused MFG, and Corporate. AMA is focused on the cultivation and sale of medical and adult-use cannabis products, and Infused MFG is focused on the manufacturing of hemp-derived CBD products. The majority of revenue is generated from the AMA segment. The operations of AMA and Infused MFG are located in the United States. All revenues are earned in the United States. | $0 | -34% | $4M | $14M | 1.2x | 20.1x | |||
Premier Health Of America Inc is a Canadian Healthtech company that provides a comprehensive range of staffing and outsourced services solutions for healthcare needs to governments, corporations, and individuals. It uses its proprietary platform for the healthcare services sector digital transformation to provide patients with faster, cheaper, and more accessible care services. The Company has two operating segments: the Per Diem segment and the Travel Nurse segment. The majority of its revenue comes from the Travel Nurse segment, which includes the Canadian Health Care Agency, Solution Staffing, Premier Health Nordik, and Solutions Nursing, four subsidiaries that offer their respective services to the federal and provincial governments for nursing and assistance, mostly in remote regions. | $0 | -83% | $200K | $32M | 0.4x | (11.4x) | |||
Delic Holdings Corp is a media, e-commerce, and event company that operates in the field of psychedelic wellness. The company spreads awareness regarding the growing space of psychedelic therapies used as possible treatments for PTSD, anxiety, depression, and other mental health conditions. The business has four distinct segments: The Delic (e-commerce website and blog), Reality Sandwich (online education platform), Meet Delic (bi-annual event), and Delic Radio (podcast), each of which is dedicated to public education and de-stigmatizing the psychedelic conversation for a mainstream audience. | $0 | -- | $9K | $9K | 0.0x | (0.0x) | |||
| Median | $0 | -34% | $40M | $40M | 3.5x | (3.0x) |
Financial data powered by FactSet and Morningstar. Valuation multiples as of current fiscal year. For more data, start your free trial here.
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.